News

A look at home and dosing site considerations.

Editor-in-Chief Lisa Henderson speak about therapeutic needs, rare diseases in children, and the SCORR Marketing survey on innovative or flexible trial designs.

Findings from a new ACT and SCORR Marketing survey reveal the most actively used flexible design approaches in clinical research-many with application in rare disease.

Leader of one longtime CRO discusses the marked changes in clinical trial practice from past to present-and the company’s unique focus.

Exploring three distinct patient partnership models to help researchers assess which methods of engagement could work best for their clinical programs.

With more common cancers now increasingly broken down by specific genomic defects, the future of research for any cancer is entirely, and unequivocally, molecular.

Outlining the unique pharmacokinetic factors that should be considered when designing and running early stage clinical trials for monoclonal antibodies.

Sobering statistics collected on clinical trial execution point to the eventual convergence of healthcare and clinical research operating environments.

As international outsourcing continues to drive the parties contributing to clinical trials farther apart, technology will increasingly serve as a means of bringing them closer together.

John Reites, THREAD’s Chief Product Officer, will discuss eDROs and the FocalView App in this interview.

Right-to-Try bill sent to White House for President’s signature after passage by Congress.

Artificial intelligence is a "new weapon" in healthcare research.

From 2019, to comply with requirements for greater transparency around clinical research as part of the EU Clinical Trials Regulation 536/2014, life sciences firms will be expected to prepare plain-language summaries for all Phase I through IV interventional trials, which can be understood by patients, the general public, and experts.

When less is more. Using three referral labs vs. one central lab.

A global CRO’s data gathered using an objective monitoring simulation administered by CRA Assessments, LLC reveals that CRAs are consistently underperforming regardless of the level of experience or training.